About the Journal

International Journal of Atherogenic Diabetic Dyslipidemia (IJADD), a triannual journal, will contain literature encompassing all the scientific and clinical aspects addressing the cause and management of atherogenic dyslipidemia.

The content of the journal shall include, but not limited to, subject areas including Diabetes Mellitus, Atherogenic Dyslipidemia, Obesity, Fatty Liver Disease, Acute pancreatitis, Hypertriglyceridemia, Pharmacological management/therapeutic options for atherogenic Dyslipidemia in type 2 diabetes and new strategies for management.

Aim of the Journal

The aim of International Journal of Atherogenic Diabetic Dyslipidemia (IJADD) is to keep doctors updatedin the current trends in therapy and new modalities of care. Our objectives are:

To be the knowledge partner for healthcare professionals by presenting contemporary research and novel treatment options in the field of atherogenic diabetic Dyslipidemia.
To raise awareness about the latest clinical practices, for better management of the condition, thus improving on the standards of overall disease management.
To provide researchers of the field with a medium to elicit thought processes with their peers working on similar innovations or experiments.
To provide clinicians a platform to showcase their case studies.